TME is a network of clinicians, researchers, educators and companies whose core mission is to improve the quality and access to advanced targeted cancer care by fostering high-quality & comprehensive educational resources and research by synthesizing “State-of-the-Art” with “State-of-the-Science.” Our specialty is breast cancer from prevention, diagnosis, treatment, to survivorship.
TME hosted its Annual Research Reception at The American Society of Breast Surgeons 23rd Annual Meeting in Las Vegas on 8 April 2022. This year’s reception was dedicated to TME Founder, Emeritus, Mark Gittleman MD.

Digistain nominated for the EIT Awards 2026
Digistain has been nominated for the EIT Awards 2026 in the Venture Award category. The Venture Award recognises organisations combining strong commercial potential with meaningful